丹参酮ⅡA磺酸钠注射液治疗冠心病心绞痛的临床效果

Clinical effect of sodium tanshinone ⅡA sulfonate injection in treatment of angina pectoris of coronary heart disease

目的探究丹参酮ⅡA磺酸钠注射液治疗冠心病心绞痛的临床效果。方法将我院收治的96例冠心病心绞痛患者随机分为观察组和对照组,各48例。两组均实施常规药物治疗,观察组在此基础上加用丹参酮ⅡA磺酸钠注射液。比较两组的治疗效果。结果治疗后,两组发作频率、持续时间、疼痛评分均显著降低,且观察组均低于对照组(P<0.05);两组胸闷、胸痛、心悸及总评分均显著降低,且观察组均低于对照组(P<0.05)。结论在常规治疗基础上加用丹参酮ⅡA磺酸钠注射液对冠心病心绞痛的治疗效果更优,可有效缓解患者的心绞痛发作,改善其临床症状,值得临床推广。

Objective To explore the clinical effect of sodium tanshinone ⅡA sulfonate injection in treatment of angina pectoris of coronary heart disease. Methods A total of 96 patients with angina pectoris of coronary heart disease were randomly divided into observation group and control group, with 48 cases in each group. Both groups were treated with routine drugs. On this basis, the observation group was treated with sodium tanshinone Ⅱ A sulfonate injection. The therapeutic effects of the two groups were compared. Results After treatment, the scores of frequency of attacks, duration and pain of the two groups significantly decreased, and those in the observation group were lower than the control group(P<0.05). The scores of chest tightness, chest pain, palpitation and total scores in both groups significantly decreased, and those in the observation group were lower than the control group(P<0.05). Conclusion On the basis of routine treatment,addition sodium tanshinone ⅡA sulfonate injection is more effective in the treatment of angina pectoris of coronary heart disease, which can effectively alleviate the attacks of angina pectoris and improve the clinical symptoms of patients. It is worthy of clinical promotion.